SCHEMBL7811170

SCHEMBL7811170

Cn1[c]nc2cccc(C(F)(F)F)c21

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 6/20 0.38
PARP1 P09874 1/20 0.34
PRPS1 P60891 1/20 0.34
ESR1 P03372 2/20 0.33
P2RX7 Q99572 1/20 0.33
KCNH2 Q12809 3/20 0.33
GRM2 Q14416 3/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ELANE P08246 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPK1 P28482 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
NOTUM Q6P988 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1829816 0.77 CYP11B2 (0.33) PARP1
SCHEMBL7804906 0.74 NPC1 (0.41) PARP1ESR1CYP1A2
SCHEMBL7818166 0.74 GRM2 (0.40) HSD11B1PARP1GRM2CYP3A4CYP2D6
SCHEMBL5840891 0.73 BACE1 (0.32) PRPS1GRM2
SCHEMBL5470183 0.68 PRMT5 (0.58) HSD11B1KCNH2GRM2CYP1A2
SCHEMBL4555147 0.67 CRHR1 (0.30)
SCHEMBL31698451 0.64 ESR1 (0.41) HSD11B1PRPS1ESR1P2RX7MAPK1
SCHEMBL2838697 0.64 BACE1 (0.35) HSD11B1ESR1ALDH1A1L3MBTL1CYP1A2
SCHEMBL7810993 0.63 PRPS1 (0.36) PRPS1GRM2
SCHEMBL22372352 0.63 PARP1 (0.38) HSD11B1PARP1ESR1P2RX7GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed